Press Releases

07-08 Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis BU
07-01 Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight BU
06-25 Agilent Completes Acquisition of Biocare Medical BU
06-03 Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation BU
06-02 Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma BU
06-01 Agilent Technologies : and Sound Analytics Collaborate to Advance LC/MS Workflows for Drug Metabolism Research PU
05-29 Agilent Technologies : Showcases Integrated Mass Spectrometry and Chromatography Solutions at ASMS 2026 PU
05-28 Agilent Introduces OpenLab Sync to Support Guided, Digital Execution in the Laboratory BU
05-27 Agilent: Fiscal Q2 Earnings Snapshot AQ
05-27 Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results BU
05-26 Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control BU
05-26 Agilent Launches New GC Systems with GC Assist to Improve Laboratory Efficiency and Data Quality BU
05-22 Agilent Unveils the 9500 ICP-MS: Redefining Trace Element Analysis BU
05-21 Agilent and Singapore's NATi Partner to Advance Lipid-Conjugated Oligonucleotide Research AQ
05-21 Agilent Launches 1290 Infinity III Fluorescence Detector for Confident Trace Analysis at UHPLC Speed BU
05-20 Agilent Announces Cash Dividend of 25.5 Cents per Share BU
05-19 Agilent to Supply Next Generation Alarm Resolution Technology to U.S. Airport Security Screening Checkpoints ahead of FIFA World Cup 2026 BU
05-14 Enablement For Validity Versus Enablement For Anticipation: Lessons From Agilent Technologies, Inc. v. Synthego Corp. AQ
05-11 Agilent to Participate in Jefferies Global Healthcare Conference BU
05-04 Agilent Names Michael Buckner as Chief Legal Officer BU
04-28 Agilent to Announce Second-Quarter Fiscal Year 2026 Financial Results on May 27 BU
04-15 Agilent Showcases Cancer Research Solutions at AACR 2026 BU
04-14 Agilent Technologies : Partners OmixAI to Expand AI-Driven Proteomics in South Korea PU
04-01 Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader BU
03-26 Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) Carcinoma BU
No results match your criteria